tiprankstipranks
Trending News
More News >
Peptidream Inc. (PPTDF)
OTHER OTC:PPTDF
Advertisement

Peptidream (PPTDF) Price & Analysis

Compare
17 Followers

PPTDF Stock Chart & Stats


Peptidream News

PPTDF FAQ

What was Peptidream Inc.’s price range in the past 12 months?
Peptidream Inc. lowest stock price was $10.00 and its highest was $22.34 in the past 12 months.
    What is Peptidream Inc.’s market cap?
    Peptidream Inc.’s market cap is $1.46B.
      When is Peptidream Inc.’s upcoming earnings report date?
      Peptidream Inc.’s upcoming earnings report date is Nov 06, 2025 which is in 43 days.
        How were Peptidream Inc.’s earnings last quarter?
        Peptidream Inc. released its earnings results on Aug 07, 2025. The company reported -$0.057 earnings per share for the quarter, missing the consensus estimate of $0.069 by -$0.127.
          Is Peptidream Inc. overvalued?
          According to Wall Street analysts Peptidream Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Peptidream Inc. pay dividends?
            Peptidream Inc. does not currently pay dividends.
            What is Peptidream Inc.’s EPS estimate?
            Peptidream Inc.’s EPS estimate is 0.22.
              How many shares outstanding does Peptidream Inc. have?
              Peptidream Inc. has 130,010,400 shares outstanding.
                What happened to Peptidream Inc.’s price movement after its last earnings report?
                Peptidream Inc. reported an EPS of -$0.057 in its last earnings report, missing expectations of $0.069. Following the earnings report the stock price went same 0%.
                  Which hedge fund is a major shareholder of Peptidream Inc.?
                  Currently, no hedge funds are holding shares in PPTDF

                  Company Description

                  Peptidream Inc.

                  PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides. It has a collaborative research and exclusive license agreement with Takeda Pharmaceutical Company Limited to develop peptide drug conjugates for neuromuscular diseases. The company was incorporated in 2006 and is headquartered in Kawasaki, Japan.

                  Peptidream (PPTDF) Earnings & Revenues

                  PPTDF Company Deck

                  PPTDF Earnings Call

                  Q2 2025
                  0:00 / 0:00
                  Earnings Call Sentiment|Positive
                  The earnings call presented a largely positive outlook for the company with strong financial performance and promising pipeline developments, despite some challenges in specific segments and uncertainties in deal closures.View all PPTDF earnings summaries
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  GNI Group
                  SanBio Co
                  Sosei Group
                  Healios KK
                  Takara Bio Inc.

                  Ownership Overview

                  2.65%93.68%
                  Insiders
                  ― Other Institutional Investors
                  93.68% Public Companies and
                  Individual Investors

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis